When you need specialized handling for your specialized research.
PRC Clinical Is the Right Clinical Research Organization for You
Clinical trial conduct is a complex process requiring an experienced partner with the agility and tenacity to creatively solve your critical challenges. PRC Clinical was purpose-built to flex to your unique needs. For early phase studies through Phase III clinical trials, our experienced team delivers high-touch approaches to ensure your trial is handled with the utmost care for high-quality results.
Your Priority Is Our Specialty
With over 15 years of experience in biotech, PRC Clinical understands the risk of starting up and conducting studies in emerging technologies. We will develop a unique approach with our staff and network of experts to rapidly scale to the trial needs and provide quality guidance and operational support to mitigate risk for your project, fast.Learn more about us
We understand the need to be prepared for anything. In unprecedented times, our flexible team works closely with you to keep trial momentum, creating customized solutions and personalized strategies to overcome your critical trial challenges.Learn more about our services
Our team works hand-in-hand with yours to determine the right approach for specialized patient populations. With therapeutic expertise in areas such as CNS (Parkinson’s and Alzheimer’s), ophthalmology, and a focus on regenerative medicine, we will ensure your study patients are enrolled and handled with the highest level of integrity.Learn more about our therapeutic expertise
Hands-On Service to Support Your Next Trial
Read the Latest From PRC Clinical
5 Tips: What Can You Do This Year to Get Your Study Ahead in 2021?
November 23, 2020
Demystifying Regenerative Medicine
November 3, 2020
Learning From the Alzheimer’s Research of the Past to Inform the Future
September 21, 2020
PRC Clinical Galvanizes Brand
October 6, 2020
The Fight Against COVID-19: PRC Clinical’s Response
April 1, 2020
PRC Clinical Advances Clinical Trials with Veeva Vault eTMF
March 27, 2020